Evidence map›Paper›PMID 41073403›Full record

ArticleNature communications2025

HAND2 invades nucleolar condensates to pioneer lineage-specific cardiac pacemaker gene programs.

Kartik Kulkarni, Gabriella Quinn, Jared Dela Rosa, Sean Goetsch, Vrushali Pandit, Lin Wang, Akane Sakaguchi, Sushama Sivakumar, Nikhil V Munshi

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Epithelial sensing of vitamin A shapes intestinal antimicrobial defense.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kartik KulkarniDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Gabriella QuinnDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jared Dela RosaDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0003-1549-4093
Sean GoetschDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Vrushali PanditDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Lin WangDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Akane SakaguchiDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0003-1449-0840
Sushama SivakumarDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-7877-4821
Nikhil V MunshiDepartment of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA. Nikhil.Munshi@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-8397-100X

Funding

Exploring Mechanisms of Cardiac Pacemaker Cell Fate DeterminationR01HL151650 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MUNSHI, NIKHIL VILAS · 2021 to 2025
$2.1M
Developing vectors for potent and selective manipulation of cardiac rhythmR01HL172898 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI NIKHIL Vilas MUNSHI · 2025 to 2026
$1.1M
Systematic Assessment of Combinatorial Transcription Factor ActivityR56HG012768 · NHGRI · UT SOUTHWESTERN MEDICAL CENTER · PI HON, GARY CHUNG, MUNSHI, NIKHIL VILAS · 2023 to 2023
$400k
Defining process control parameters for cardiac reprogrammingR03HL135217 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MUNSHI, NIKHIL VILAS · 2016 to 2017
$162k
American Heart Association (American Heart Association, Inc.) 23TPA1140364NHGRI NIH HHS R56 HG012768NHLBI NIH HHS R01 HL151650NHLBI NIH HHS R01 HL172898NHLBI NIH HHS R03 HL135217U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL135217U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL151650U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) HG012768
6 · The paper itself

Abstract

Although best known as the site for ribosome assembly, the nucleolus organizes heterochromatin into transcriptionally repressed Nucleolus-Associated Domains (NADs). NADs harbor many genes involved in cell-type specification, yet the mechanisms by which transcription factors (TFs) access this heterochromatin to activate gene expression remain unknown. Using a model of TF-induced cardiac pacemaker reprogramming, we conclusively establish that nucleolar localization of HAND2 is required for successful lineage conversion. Moreover, we perform unbiased transcriptional profiling to demonstrate that pacemaker gene programs are highly compartmentalized within the nucleus. Finally, we show that HAND2 homodimers invade nucleolar condensates and concentrate within the nucleolus to bind palindromic motifs required for activating lineage-specific enhancers buried within NADs. Taken together, our data highlight a key role for the nucleolus in orchestrating pacemaker gene expression by HAND2. More broadly, these results suggest that TF localization to sub-nuclear heterochromatin domains may represent a potent strategy for activating lineage-specific gene programs.

Indexed as

Basic Helix-Loop-Helix ProteinsCell NucleolusAnimalsCell LineageEnhancer Elements, GeneticHeterochromatinHumansMiceMyocytes, CardiacBasic Helix-Loop-Helix ProteinsHand2 protein, mouseHeterochromatin

Identifiers

PMID41073403
PMCPMC12514281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.